In addition, the downstream changes in four transcription factors (STAT1, NFKB1, MCM6, and SPI1) are significantly large (0.1 FDR), suggesting that these factors are significant sources of variance in ovarian cancer. This evidence concerns the gene NFKB1 and ovarian carcinoma.